IRIS
MORONCINI, Gianluca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.856
EU - Europa 4.512
AS - Asia 4.143
SA - Sud America 1.074
Continente sconosciuto - Info sul continente non disponibili 441
AF - Africa 247
OC - Oceania 11
Totale 19.284
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.633
SG - Singapore 1.275
IT - Italia 1.187
VN - Vietnam 894
BR - Brasile 848
RU - Federazione Russa 722
CN - Cina 690
DE - Germania 443
HK - Hong Kong 418
UA - Ucraina 418
SE - Svezia 325
IE - Irlanda 311
FR - Francia 277
TR - Turchia 193
GB - Regno Unito 169
FI - Finlandia 166
BD - Bangladesh 151
DK - Danimarca 149
IN - India 113
CA - Canada 97
CI - Costa d'Avorio 96
NL - Olanda 85
KR - Corea 82
MX - Messico 76
AR - Argentina 70
PL - Polonia 57
AT - Austria 50
JP - Giappone 49
ZA - Sudafrica 48
EC - Ecuador 47
ES - Italia 39
IQ - Iraq 39
MA - Marocco 39
ID - Indonesia 34
PK - Pakistan 33
CO - Colombia 31
VE - Venezuela 22
BE - Belgio 20
CL - Cile 19
IL - Israele 18
PY - Paraguay 17
TN - Tunisia 17
UZ - Uzbekistan 17
MY - Malesia 15
PH - Filippine 15
SA - Arabia Saudita 15
AE - Emirati Arabi Uniti 11
EG - Egitto 11
LT - Lituania 11
NP - Nepal 11
CR - Costa Rica 10
DZ - Algeria 10
AL - Albania 9
JO - Giordania 9
AU - Australia 8
PE - Perù 8
RO - Romania 8
RS - Serbia 8
UY - Uruguay 8
CH - Svizzera 7
DO - Repubblica Dominicana 7
JM - Giamaica 7
KE - Kenya 7
PS - Palestinian Territory 7
TW - Taiwan 7
HN - Honduras 6
PT - Portogallo 6
AZ - Azerbaigian 5
EE - Estonia 5
ET - Etiopia 5
EU - Europa 5
KZ - Kazakistan 5
NI - Nicaragua 5
OM - Oman 5
TH - Thailandia 5
BA - Bosnia-Erzegovina 4
CZ - Repubblica Ceca 4
GR - Grecia 4
GT - Guatemala 4
HR - Croazia 4
KW - Kuwait 4
LB - Libano 4
NO - Norvegia 4
SK - Slovacchia (Repubblica Slovacca) 4
BB - Barbados 3
BO - Bolivia 3
GE - Georgia 3
HU - Ungheria 3
IR - Iran 3
MD - Moldavia 3
SV - El Salvador 3
CW - ???statistics.table.value.countryCode.CW??? 2
GA - Gabon 2
KG - Kirghizistan 2
LU - Lussemburgo 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
PA - Panama 2
SI - Slovenia 2
SN - Senegal 2
Totale 18.820
Salva come PNG Salva come JPEG
Città #
Ashburn 1.463
Singapore 757
Chandler 621
San Jose 546
Dallas 528
Jacksonville 430
Council Bluffs 407
Hong Kong 406
Fairfield 334
Ho Chi Minh City 307
Dublin 305
Boardman 290
Des Moines 264
New York 228
Hanoi 195
Wilmington 190
The Dalles 188
Beijing 184
Los Angeles 175
Houston 155
Woodbridge 155
Centro 149
Lauterbourg 146
Seattle 137
Munich 133
Moscow 132
Ancona 117
Ann Arbor 115
Princeton 112
Lawrence 108
Milan 102
Abidjan 96
San Mateo 92
São Paulo 92
Cambridge 80
Hefei 80
Santa Clara 73
Chicago 68
Orem 59
Buffalo 56
Helsinki 55
Nuremberg 51
London 46
Redmond 45
Turin 44
Da Nang 41
Haiphong 41
Mexico City 38
Turku 38
Warsaw 38
Tokyo 37
San Diego 35
Shanghai 35
Atlanta 34
Rome 34
Frankfurt am Main 33
Montreal 33
Rio de Janeiro 31
Marche 30
Tolentino 30
Chennai 29
Johannesburg 28
Salt Lake City 26
Amsterdam 24
Brasília 23
Brooklyn 23
Washington 23
Phoenix 22
Guangzhou 21
Poplar 20
Stockholm 20
Vienna 20
Belo Horizonte 19
Denver 19
Jesi 17
Porto Alegre 17
Boston 16
Columbus 16
Florence 16
Manchester 16
Pune 16
Brussels 15
Curitiba 15
San Francisco 15
Tashkent 15
Wuhan 15
Guayaquil 14
Guarulhos 13
Sterling 13
Ankara 12
Baghdad 12
Biên Hòa 12
Bắc Ninh 12
Elk Grove Village 12
Hải Dương 12
Jiaxing 12
Naples 12
Quito 12
Toronto 12
Falls Church 11
Totale 11.521
Salva come PNG Salva come JPEG
Nome #
Insights from comparison of serum IgG4 between T2-eosinophilic asthma and eosinophilic granulomatosis with polyangiitis/idiopathic hypereosinophilic syndrome 257
An international SUrvey on non-iNvaSive tecHniques to assess the mIcrocirculation in patients with RayNaud'€™s phEnomenon (SUNSHINE survey) 244
Overview of Curcumin and Piperine Effects on Glucose Metabolism: The Case of an Insulinoma Patient’s Loss of Consciousness 239
The value of admission Troponin I to predict outcomes in suspected infections in elderly patients admitted in Internal Medicine: results from the SOFA-T collaboration, a multi-center study 216
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease 211
The first outstanding 50 years of “Università Politecnica delle Marche”: Research achievements in life sciences 202
Development of the optimal touchscreen interface for patients with scleroderma 192
Characterization of binding and quantification of human autoantibodies to PDGFRα using a biosensor-based approach 192
Induction of Scleroderma Fibrosis in Skin-Humanized Mice by Administration of Anti−Platelet-Derived Growth Factor Receptor Agonistic Autoantibodies 191
ANCA-negative EGPA: only eosinophils without vasculitis? Insights from anti-T2 biologics 189
Atrial Fibrillation on Patients with Vascular Dementia: A Fundamental Target for Correct Management 189
Preface 187
SOFA and qSOFA usefulness for in-hospital death prediction of elderly patients admitted for suspected infection in internal medicine 184
Adalimumab modulates angiogenesis in psoriatic skin 175
Developments in the management of advanced soft-tissue sarcoma –€“ Olaratumab in context 174
Erratum: Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance [Radiol med, DOI 10.1007/s11547-014-0419-7] 166
SARS-COV-2 Infection, Vaccination, and Immune-Mediated Diseases: Results of a Single-Center Retrospective Study 165
6 and 12 month outcomes in patients following COVID-19-related hospitalization: a prospective monocentric study 163
Agonistic anti-PDGF receptor autoantibodies from patients with systemic sclerosis impact human pulmonary artery smooth muscle cells function in vitro 161
Epitope specificity determines pathogenicity and detectability of anti-platelet-derived growth factor receptor α autoantibodies in systemic sclerosis 161
Ha-Ras stabilization mediates pro-fibrotic signals in dermal fibroblasts. 156
A reactive Oxygen species -mediated loop mantains increased expression of NADPH oxidases 2 and 4 in skin fibroblasts from patients with systemic sclerosis 154
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease 152
Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs. 151
Impact of atrial fibrillation in critically ill patients admitted to a stepdown unit 150
The ATTRACT study: screening for the early identification of axial psoriatic arthritis in a cohort of Italian psoriatic patients 150
B CELL RECEPTOR EDITING IN SCLERODERMA PATIENTS GENERATES PATHOGENIC ANTI-PDGFR AUTOANTIBODIES 150
Mesenchymal stromal cells from human umbilical cord prevent the development of lung fibrosis in immunocompetent mice 150
Biosensor-based Binding Assay for Platelet-Derived Growth Factor Receptor-α Autoantibodies in Human Serum 149
Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies 149
Long lasting biological effects of PDGFR agonistic auto-antibodies in scleroderma 148
Analysis of ATP8B4 F436L missense variant in a large systemic sclerosis cohort 148
Hypothalamic-pituitary-adrenal axis disregulation in PrPC-null mice. 147
Echocardiographic predictors of mortality in intermediate-risk pulmonary embolism 146
Improving the EHMRG Prognostic Evaluation of Acute Heart Failure with TAPSE/PASp: A Sequential Approach 142
Effects of prophylactic drug therapies and anti-calcitonin peptide-related monoclonal antibodies on subjective sleep quality: An Italian multicenter study 136
Clusters of Comorbidities in the Short-Term Prognosis of Acute Heart Failure among Elderly Patients: A Retrospective Cohort Study 135
Risk prediction of clinical adverse outcomes with machine learning in a cohort of critically ill patients with atrial fibrillation 135
DETECTION OF STIMULATORY ANTI-PDGF RECEPTOR AUTOANTIBODIES BY BIOASSAYS BASED ON DIFFERENT CELL LINES 134
Biologics in inflammatory immune-mediated systemic diseases 134
A machine learning analysis to predict the response to intravenous and subcutaneous immunoglobulin in inflammatory myopathies. A proposal for a future multi-omics approach in autoimmune diseases 133
Agonistic antibodies in systemic sclerosis 133
PDGF/PDGFR: A Possible Molecular Target in Scleroderma Fibrosis 133
Systemic Sclerosis: From Pathophysiology to Novel Therapeutic Approaches 132
AUTOIMMUNITY TO PDGFR: A RELEVANT PATHOGENIC LINK IN SSc 131
Isolation of agonistic autoantibodies specific for the PDGF receptor from the B cell repertoire of SSC patients 128
Mycophenolate mofetil-induced colitis in a patient with systemic sclerosis 127
Pathogenic autoantibodies in systemic sclerosis 126
Cloning of agonistic autoantibodies specific for the PDGF receptor from the B-cell repertoire of SSc patients 126
History and scientific production of clinica medica and clinica ematologica in ancona 126
CLONING OF AGONISTIC AUTOANTIBODIES SPECIFIC FOR THE PDGF RECEPTOR FROM THE B CELL REPERTOIRE OF PATIENTSAFFECTED BY SYSTEMIC SCLEROSIS 125
Update of EULAR recommendations for the treatment of systemic sclerosis 125
Increased expression of the ectoenzyme CD38 in peripheral blood plasmablasts and plasma cells of patients with systemic sclerosis 123
Immunohistochemical detection and localization of somatostatin receptor subtypes in prostate tissue from patients with bladder outlet obstruction. 122
Autoantibodies against the platelet-derived growth factor receptor in scleroderma: comment on the articles by Classen et al and Loizos et al. 122
Mechanism of action of agonistic PDGFR auto-antibodies isolated from scleroderma patients 122
Comment on 'Where are we going in the management of interstitial lung disease in patients with systemic sclerosis?' 122
Induction of Mouse Lung Injury by Endotracheal Injection of Bleomycin 121
Replacement and Immunomodulatory Activities of 20% Subcutaneous Immunoglobulin Treatment: A Single-Center Retrospective Study in Autoimmune Myositis and CVID Patients 121
Contributions of neuronal prion protein on sleep recovery and stress response following sleep deprivation. 120
Regional implantation of autologous adipose tissue-derived cells induces a prompt healing of long-lasting indolent digital ulcers in patients with systemic sclerosis 120
Early administration of tofacitinib in COVID-19 pneumonitis: An open randomised controlled trial 119
The Wnt signalling inhibitor gene, WIF1, is silenced in fibroblasts derived from Systemic Sclerosis patients: role of oxidative stress 119
NADPH oxidase, oxidative stress and fibrosis in systemic sclerosis 119
Detection of typical and atypical bovine spongiform encephalopathy and scrapie prion strains by prion protein motif-grafted antibodies. 119
BIOLOGIC THERAPY IN INFLAMMATORY IMMUNOMEDIATED SYSTEMIC DISEASES: SAFETY PROFILE 119
Cutting-Edge Techniques and Drugs for the Treatment of Pulmonary Embolism: Current Knowledge and Future Perspectives 119
Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance 118
Common Variable Immunodeficiency in Elderly Patients: A Long-Term Clinical Experience 118
Clinical method applied to focused ultrasound: The case of wells’ score and echocardiography in the emergency department: A systematic review and a meta-analysis 118
Adeno-associated virus type 5 infection via PDGFRα is associated with Interstitial lung disease in systemic sclerosis and generates composite peptides and epitopes recognized by the agonistic immunoglobulins present in patients with systemic sclerosis 117
Implementation of EHMRG Risk Model in an Italian Population of Elderly Patients with Acute Heart Failure 117
WIF1, A WNT PATHWAY INHIBITOR, IS SILENCED IN SYSTEMIC SCLEROSIS BY DNA DAMAGE: A MECHANISM LINKING DNA DAMAGE TO WNT AND FIBROSIS 117
MOTIF-GRAFTED HYBRID POLYPEPTIDES AND USES THEREOF 117
Putative functional pathogenic autoantibodies in systemic sclerosis 117
Influence of TYK2 in systemic sclerosis susceptibility: A new locus in the IL-12 pathway 116
Detection of typical and atypical BSE and scrapie prion strains by prion protein motif-grafted antibodies. 111
Oxidative DNA damage induces the ATM-mediated transcriptional suppressionof the Wnt inhibitor WIF-1 in systemic sclerosis and fibrosis 111
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways 111
Isolation and cloning of stimulatory anti-PDGF receptor auto-antibodies from the immunological repertoire of patients with systemic sclerosis 110
Reactivation of Hepatitis B Virus Infection Associated with Anti-Tumor Necrosis Factor-α Therapy 110
Oxidative stress and the pathogenesis of scleroderma: the Murrell's hypothesis revisited. 109
Reduced type I collagen gene expression by skin fibroblasts of patients with systemic sclerosis after one treatment course with rituximab 109
Downregulation of GPR83 in the hypothalamic preoptic area reduces core body temperature and elevates circulating levels of adiponectin. 109
The Relationship between Post-COVID Syndrome and the Burden of Comorbidities Assessed Using the Charlson Comorbidity Index 108
Role of viral infections in the etiopathogenesis of systemic sclerosis 108
Development of A Solid Phase Binding Assay For Detection of Conformational Anti-PDGFR Autoantibodies In the Serum of Patients Affected By Scleroderma 107
Stimulatory autoantibodies to the PDGF receptor: a link to fibrosis in scleroderma and a pathway for novel therapeutic targets 107
Scleroderma-like fibrosis in chronic graft-vs-host disease is sustained by anti-PDGF receptors antibodies 106
PDGF receptor as therapeutic and diagnostic target in systemic sclerosis 106
Isolation and cloning of stimulatory anti-PDGF receptor auto-antibodies from the immunological repertoire of patients with systemic sclerosis 105
Development of a conformation-dependent immunoassay for the diagnosis of systemic sclerosis 105
Low-dose Oral Imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide. A phase II pilot study 105
Treatment With Rituximab Reduces Activation Of Scleroderma Dermal Fibroblasts 104
Delection of typical and atypical bovine spongiform encephalopathy and scraipe prion strains by prion protein motif-grafted antibodies 103
Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort 102
Efficacy and safety of intravenous and subcutaneous tocilizumab in a cohort of patients affected by rheumatoid arthritis in real-life 102
Platelet-activating factor acetylhydrolase: A biomarker in Hymenoptera venom allergy? 102
Axial psoriatic arthritis in patients not fulfilling the back pain entry features of the ASAS Classification Criteria for Axial Spondyloarthritis: findings from the ATTRACT Study 101
Development of a conformation-dependent immunoassay for the diagnosis of systemic sclerosis 101
Totale 13.733
Salva come PNG Salva come JPEG
Categoria #
all - tutte 84.774
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.774
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022821 0 190 23 29 22 43 20 53 83 57 125 176
2022/20231.821 148 189 128 162 113 403 9 101 382 24 122 40
2023/20241.153 163 38 66 138 167 233 21 51 11 82 57 126
2024/20252.871 319 259 75 48 128 119 345 128 585 190 282 393
2025/20268.821 581 639 650 909 962 516 1.513 782 736 743 404 386
2026/2027805 580 225 0 0 0 0 0 0 0 0 0 0
Totale 19.284